Baricinix 4 mg contains Baricitinib, an oral Janus kinase (JAK) inhibitor used in the management of certain autoimmune and inflammatory conditions. It works by targeting specific enzymes involved in the inflammatory process, thereby reducing immune system overactivity that leads to tissue damage and chronic symptoms. Baricinix 4 mg is formulated to provide effective disease control with convenient once-daily oral dosing.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Active ingredient: Baricitinib 4 mg
Dosage form: Oral tablet
Janus Kinase (JAK) inhibitor
Immunomodulatory agent
Baricitinib selectively inhibits JAK1 and JAK2 enzymes, which play a key role in cytokine-mediated signaling pathways involved in inflammation and immune responses. By blocking these pathways, Baricinix 4 mg helps reduce inflammatory activity, pain, swelling, and progression of autoimmune disease. This targeted mechanism allows for effective symptom control while minimizing widespread immune suppression.
Baricinix 4 mg is indicated for the treatment of:
Moderate to severe Rheumatoid Arthritis in adults who have had an inadequate response to one or more disease-modifying antirheumatic drugs (DMARDs)
Other inflammatory or autoimmune conditions as prescribed by a healthcare professional, based on clinical judgment and approved guidelines
The usual recommended dose is 4 mg once daily, taken orally with or without food.
Dose adjustments may be required in patients with renal impairment or based on tolerability.
Baricinix 4 mg should be taken exactly as prescribed by a qualified healthcare professional.
Convenient once-daily oral therapy
Targeted action on key inflammatory pathways
Helps reduce joint pain, stiffness, and swelling
May slow disease progression and improve physical function
Suitable for long-term management under medical supervision
Baricinix 4 mg should be used with caution in patients with a history of infections, as it may increase the risk of serious infections.
Regular monitoring of blood counts, liver enzymes, and lipid levels is recommended during treatment.
Not recommended during pregnancy or breastfeeding unless clearly advised by a physician.
Patients should inform their doctor about any existing medical conditions or concomitant medications before starting therapy.
Common side effects may include upper respiratory tract infections, headache, nausea, and changes in laboratory parameters. Serious adverse effects are uncommon but may include infections or blood abnormalities, requiring prompt medical attention.
Store below 30°C
Protect from moisture and light
Keep out of reach of children
Baricinix 4 mg is a reliable and effective option for patients requiring advanced immunomodulatory therapy. When used under proper medical guidance, it offers meaningful relief from inflammatory symptoms and supports improved quality of life in chronic autoimmune conditions.
Login Or Registerto submit your questions to seller
No none asked to seller yet